General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-08-09 | 2023-06 | 0 | N/A | N/A | N/A |
2023-05-09 | 2023-03 | 0 | N/A | N/A | N/A |
2023-02-28 | 2022-12 | 0 | N/A | N/A | N/A |
2020-11-03 | 2020-09 | 1.38 | N/A | N/A | N/A |
2020-08-04 | 2020-06 | 1.25 | N/A | N/A | N/A |
2020-05-05 | 2020-03 | 1.41 | N/A | N/A | N/A |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-03-13 | BISARO PAUL M. | Director | 74.82K | Purchase |
2023-01-02 | GOLDMAN NEAL P | Director | 52.55K | Stock Award(Grant) |
2023-03-15 | GOODSON JASON DANIEL | Officer | 38.68K | Purchase |
2023-01-02 | LING KAREN | Director | 52.55K | Stock Award(Grant) |
2023-01-02 | MYERS WOODROW A JR | Director | 52.55K | Stock Award(Grant) |
2023-03-12 | OLAFSSON SIGURDUR O | Chief Executive Officer | 228.27K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-03-30 | Bracebridge Capital, LLC | 2.03M | 1.91M | 15.44% |
2023-03-30 | JP Morgan Chase & Company | 1.68M | 1.58M | 12.77% |
2023-03-30 | Hudson Bay Capital Management Lp | 1.14M | 1.07M | 8.67% |
2023-03-30 | Alta Fundamental Advisers LLC | 732.09K | 688.17K | 5.56% |
2023-03-30 | Federated Hermes, Inc. | 708.40K | 665.90K | 5.38% |
2023-03-30 | Sculptor Capital LP | 694.65K | 652.97K | 5.27% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-01-30 | Federated Hermes Institutional High Yield Bond Fund | 502.16K | 472.03K | 3.81% |
2022-12-30 | Vanguard Total Stock Market Index Fund | 454.50K | 427.23K | 3.45% |
2022-11-29 | JP Morgan High Yield Bond Fund | 193.35K | 181.75K | 1.47% |
2022-12-30 | Vanguard Extended Market Index Fund | 154.80K | 145.51K | 1.18% |
2022-12-30 | Federated Hermes Core Tr-High Yield Bond Port | 142.61K | 134.05K | 1.08% |
2022-11-29 | JP Morgan Strategic Income Opportunities Fund | 71.02K | 66.76K | 0.54% |
$MNK Breathe in, breathe out, repeat.
$MNK Great people are humble.
$MNK buyers were looking for the bottom. It’s there. They buy.
$MNK doubled my position. Now 20 000 shares.
$MNK look the other way, come back tomorrow...
Own endo and mnk thinking of adding to my positions
$MNK maybe 5$ before 15$...
Agreed still a screaming buy
My thoughts have always been you can wipe out company’s for selling legal fda approved drugs unless it’s oxy. Period. This is a long game with all or nothing. But upside is sooooo Devine
Own ENDP and MNK 2000k shares around 2.00 could more be going on then we know? Sure seems to be
$MNK. Buying at discount price again!
$MNK 15 000 @ 2.94. May add a few thousand.
Lions patiently waiting to destroy the sheep following blindly.
$MNK I am becoming confused... Can someone provide a timeline of the upcoming trials involving opioid makers?
$MNK Thank you so much Robert s. As I said before I am a psychologist. It is my first time as a trader in that kind of situation. I appreciate so much to learn by reading all your posts and everything I can find on the subject, but sometimes I miss technical knowledge. So thank you for your explanation on how the shorts can keep the price down. I welcome all explanations.
$MNK Bagholders as you say are excited over the huge amount of cash they will get soon enough.
$MNK What is choking it???
$MNK Tolerance to frustration exercise...
$MNK Added 4K on the dip.